- 5 Résultats
prix le plus bas: € 171,49, prix le plus élevé: € 235,39, prix moyen: € 213,85
1
Therapeutic Angiogenesis for Vascular Diseases : Molecular Mechanisms and Targeted Clinical Approaches for the Treatment of Angiogenic Disease - Mark Slevin
Commander
sur AbeBooks.de
€ 196,91
Envoi: € 0,001
CommanderLien sponsorisé
Mark Slevin:

Therapeutic Angiogenesis for Vascular Diseases : Molecular Mechanisms and Targeted Clinical Approaches for the Treatment of Angiogenic Disease - edition reliée, livre de poche

2010, ISBN: 9048194946

[EAN: 9789048194940], Neubuch, [PU: Springer Netherlands], GENETIK / HUMANGENETIK; KREBS (KRANKHEIT); TUMOR KREBS; NEURO.; NEUROLOGIE (KRANKHEIT) ONKOLOGIE; ONKOLOGIE - RADIOONKOLOGIE; IM… Plus…

NEW BOOK. Frais d'envoiVersandkostenfrei. (EUR 0.00) AHA-BUCH GmbH, Einbeck, Germany [51283250] [Rating: 5 (von 5)]
2
Therapeutic Angiogenesis for Vascular Diseases - Mark Slevin
Commander
sur lehmanns.de
€ 235,39
Envoi: € 0,001
CommanderLien sponsorisé

Mark Slevin:

Therapeutic Angiogenesis for Vascular Diseases - edition reliée, livre de poche

2010, ISBN: 9789048194940

Molecular Mechanisms and Targeted Clinical Approaches for the Treatment of Angiogenic Disease, Buch, Hardcover, Angiogenesis is the growth of new blood vessels and is a key process which … Plus…

Frais d'envoisofort lieferbar. (EUR 0.00)
3
Therapeutic Angiogenesis for Vascular Diseases: Molecular Mechanisms and Targeted Clinical Approaches for the Treatment of Angiogenic Disease
Commander
sur amazon.co.uk
£ 146,94
(environ € 171,49)
Envoi: € 5,601
CommanderLien sponsorisé
Therapeutic Angiogenesis for Vascular Diseases: Molecular Mechanisms and Targeted Clinical Approaches for the Treatment of Angiogenic Disease - edition reliée, livre de poche

2010

ISBN: 9789048194940

Editor: Slevin, Mark, Springer, Hardcover, Auflage: 2011, 446 Seiten, Publiziert: 2010-10-13T00:00:01Z, Produktgruppe: Book, Hersteller-Nr.: 29750280, 0.92 kg, Books Global Store, Special… Plus…

Frais d'envoiDie angegebenen Versandkosten können von den tatsächlichen Kosten abweichen. (EUR 5.60)
4
Therapeutic Angiogenesis for Vascular Diseases Molecular Mechanisms and Targeted Clinical Approaches for the Treatment of Angiogenic Disease - Slevin, Mark (Herausgeber)
Commander
sur Achtung-Buecher.de
€ 235,39
Envoi: € 0,001
CommanderLien sponsorisé
Slevin, Mark (Herausgeber):
Therapeutic Angiogenesis for Vascular Diseases Molecular Mechanisms and Targeted Clinical Approaches for the Treatment of Angiogenic Disease - edition reliée, livre de poche

2010, ISBN: 9048194946

Gebundene Ausgabe Genetik / Humangenetik, Humangenetik, Krebs (Krankheit), Tumor / Krebs, Neuro..., Neurologie / Neuro..., Forschung (medizinisch, psychologisch), Heilkunde, Humanmedizin… Plus…

Frais d'envoiVersandkostenfrei innerhalb der BRD. (EUR 0.00) MARZIES.de Buch- und Medienhandel, 14621 Schönwalde-Glien
5
Commander
sur AbeBooks.de
€ 230,07
Envoi: € 1,741
CommanderLien sponsorisé
Mark Slevin:
Therapeutic Angiogenesis for Vascular Diseases : Molecular Mechanisms and Targeted Clinical Approaches for the Treatment of Angiogenic Disease - edition reliée, livre de poche

2010, ISBN: 9048194946

[EAN: 9789048194940], Neubuch, [PU: Springer], PRINT ON DEMAND Book; New; Fast Shipping from the UK., Books

NEW BOOK. Frais d'envoi EUR 1.74 Ria Christie Collections, Uxbridge, United Kingdom [59718070] [Rating: 5 (von 5)]

1Comme certaines plateformes ne transmettent pas les conditions d'expédition et que celles-ci peuvent dépendre du pays de livraison, du prix d'achat, du poids et de la taille de l'article, d'une éventuelle adhésion de la plateforme, d'une livraison directe par la plateforme ou via un prestataire tiers (Marketplace), etc. il est possible que les frais de livraison indiqués par eurolivre ne correspondent pas à ceux de la plateforme qui propose l'article.

Données bibliographiques du meilleur livre correspondant

Détails sur le livre
Therapeutic Angiogenesis for Vascular Diseases: Molecular Mechanisms and Targeted Clinical Approaches for the Treatment of Angiogenic Disease

Angiogenesis is the growth of new blood vessels and is a key process which occurs during pathological disease progression. Excessive and damaging angiogenesis occurs in diseases such as cancer, diabetic retinopathies, age-related macular degeneration and atherosclerosis. In other diseases such as stroke and myocardial infarction, insufficient or improper angiogenesis results in tissue loss and ultimately higher morbidity and mortality. In this book we will begin by providing the reader with an overview of the process of angiogenesis including normal embryological development of blood vessels. The following chapters will each focus on a key angiogenic disease incorporating current scientific knowledge concerning the causes of activation of the "angiogenic switch", pathological consequences, current treatment options and future perspectives. Where appropriate, results from pre-clinical trials, novel imaging modalities and nanotechnological approaches will be incorporated into these sections. Finally, since it is now believed that the process of angiogenesis operated via different signalling mechanisms in different vascular beds, we will discuss our current understanding of this phenomenon. The target audience for this book would include researchers in all the basic sciences; post-graduate students at Universities and Institutes; pharmaceutical industries; clinicians working in vascular biology or tissue imaging; pathologists; neurologists; tumour biologists; ophthalmologists and cardiologists.

Informations détaillées sur le livre - Therapeutic Angiogenesis for Vascular Diseases: Molecular Mechanisms and Targeted Clinical Approaches for the Treatment of Angiogenic Disease


EAN (ISBN-13): 9789048194940
ISBN (ISBN-10): 9048194946
Version reliée
Date de parution: 2010
Editeur: Springer
430 Pages
Poids: 0,924 kg
Langue: eng/Englisch

Livre dans la base de données depuis 2007-02-10T07:43:03+01:00 (Paris)
Page de détail modifiée en dernier sur 2023-07-07T02:47:54+02:00 (Paris)
ISBN/EAN: 9789048194940

ISBN - Autres types d'écriture:
90-481-9494-6, 978-90-481-9494-0
Autres types d'écriture et termes associés:
Auteur du livre: mark
Titre du livre: therapeutic angiogenesis for vascular diseases molecular mechanisms and targeted clinical approaches for the treatment angiogenic disease


Données de l'éditeur

Auteur: Mark Slevin
Titre: Therapeutic Angiogenesis for Vascular Diseases - Molecular Mechanisms and Targeted Clinical Approaches for the Treatment of Angiogenic Disease
Editeur: Springer; Springer Netherland
430 Pages
Date de parution: 2010-10-13
Dordrecht; NL
Imprimé / Fabriqué en
Poids: 0,916 kg
Langue: Anglais
213,99 € (DE)
219,99 € (AT)
236,00 CHF (CH)
POD
XVI, 430 p.

BB; Cancer Research; Hardcover, Softcover / Medizin/Nichtklinische Fächer; Onkologie; Verstehen; Angiogenesis; Imaging; Therapy; Oncology; Molecular Medicine; Neurosciences; Human Genetics; Cancer Biology; Oncology; Biomedical Research; Neuroscience; Medical Genetics; Medizinische Forschung; Neurowissenschaften; Genetik, Medizin; BC; EA

Angiogenesis is the growth of new blood vessels and is a key process which occurs during pathological disease progression. Excessive and damaging angiogenesis occurs in diseases such as cancer, diabetic retinopathies, age-related macular degeneration and atherosclerosis. In other diseases such as stroke and myocardial infarction, insufficient or improper angiogenesis results in tissue loss and ultimately higher morbidity and mortality. In this book we will begin by providing the reader with an overview of the process of angiogenesis including normal embryological development of blood vessels. The following chapters will each focus on a key angiogenic disease incorporating current scientific knowledge concerning the causes of activation of the “angiogenic switch”, pathological consequences, current treatment options and future perspectives. Where appropriate, results from pre-clinical trials, novel imaging modalities and nanotechnological approaches will be incorporated into these sections. Finally, since it is now believed that the process of angiogenesis operated via different signalling mechanisms in different vascular beds, we will discuss our current understanding of this phenomenon. The target audience for this book would include researchers in all the basic sciences; post-graduate students at Universities and Institutes; pharmaceutical industries; clinicians working in vascular biology or tissue imaging; pathologists; neurologists; tumour biologists; ophthalmologists and cardiologists.

< pour archiver...